Madrigal Pharmaceuticals ... (MDGL)
NASDAQ: MDGL
· Real-Time Price · USD
422.99
-3.85 (-0.90%)
At close: Sep 25, 2025, 3:59 PM
422.99
0.00%
After-hours: Sep 25, 2025, 05:33 PM EDT
Madrigal Pharmaceuticals Revenue Breakdown
| Period Ending | Jun 30, 2025 |
|---|---|
| Reportable Segment Revenue | 212.8M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 196.86M | 167.88M | 141.22M | 107.58M | 105.45M | 80.8M | 46.54M | 27.58M | 17.84M | 16.18M | 14.56M | 12.14M | 11.77M | 9.66M | 11.71M | 8.29M | 10.11M | 7.21M | 6.13M | 5.49M | 5.64M | 4.61M | 5.04M | 4.75M | 7.11M | 5.75M | 5.58M | 5.12M | 2.72M | 1.87M | 2.4M | 1.96M | 1.62M | 1.7M | 2.23M | 6.29M | 3.59M | 3.04M | 3.13M | 2.98M | 3.13M | 4.15M |
| Selling, General, and Administrative Revenue Growth | +17.26% | +18.87% | +31.27% | +2.03% | +30.50% | +73.63% | +68.71% | +54.57% | +10.28% | +11.16% | +19.90% | +3.12% | +21.91% | -17.54% | +41.33% | -18.03% | +40.24% | +17.68% | +11.50% | -2.57% | +22.45% | -8.70% | +6.23% | -33.22% | +23.74% | +2.92% | +9.00% | +88.52% | +45.22% | -22.01% | +22.71% | +20.46% | -4.25% | -24.06% | -64.49% | +75.00% | +18.16% | -3.00% | +5.13% | -4.67% | -24.65% | n/a |
| Research and Development Revenue | 53.7M | 44.17M | 25.65M | 68.74M | 70.82M | 71.07M | 70.5M | 70.95M | 68.61M | 62.15M | 70.74M | 68.27M | 58.5M | 47.93M | 52.89M | 54.87M | 51.63M | 45.77M | 53.43M | 53.29M | 44.69M | 33.4M | 24.91M | 19.45M | 15.59M | 12.37M | 8.87M | 6.21M | 5.11M | 5.2M | 6.51M | 6.68M | 6.82M | 4.38M | 5.52M | 7.8M | -103K | 3.41M | 7.25M | 14.41M | 16.38M | 16.18M |
| Research and Development Revenue Growth | +21.58% | +72.22% | -62.69% | -2.94% | -0.34% | +0.81% | -0.64% | +3.42% | +10.38% | -12.14% | +3.62% | +16.70% | +22.05% | -9.38% | -3.62% | +6.28% | +12.81% | -14.33% | +0.26% | +19.25% | +33.80% | +34.08% | +28.09% | +24.71% | +26.03% | +39.48% | +42.83% | +21.57% | -1.71% | -20.18% | -2.54% | -1.97% | +55.62% | -20.71% | -29.22% | -7677.67% | -103.02% | -52.98% | -49.73% | -11.99% | +1.21% | n/a |